Target type: biologicalprocess
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of a nitric-oxide synthase enzyme. [GOC:ai]
Negative regulation of nitric-oxide synthase biosynthetic process refers to the cellular mechanisms that decrease the production of nitric oxide synthase (NOS), an enzyme responsible for generating nitric oxide (NO). NO is a highly reactive signaling molecule with diverse functions in the body, including vasodilation, neurotransmission, and immune regulation. Excessive NO production can lead to pathological conditions, such as inflammation and oxidative stress, therefore tight regulation of NOS activity is crucial for maintaining homeostasis. Negative regulation of NOS biosynthesis can occur at multiple levels, including:
1. **Transcriptional Regulation:**
- Reduced expression of NOS genes can be achieved by various transcription factors, such as NF-κB, AP-1, and STATs, that bind to regulatory elements in the promoter region of NOS genes, ultimately inhibiting the transcription of mRNA.
- MicroRNAs (miRNAs) can also target NOS mRNA for degradation or translational inhibition, resulting in reduced NOS production.
2. **Post-Translational Modifications:**
- Phosphorylation: NOS activity can be regulated by kinases that phosphorylate specific amino acid residues on the enzyme, leading to either activation or inactivation. For example, phosphorylation of eNOS by Akt promotes its activity, while phosphorylation by PKA inhibits it.
- Ubiquitination: Ubiquitination is a process where ubiquitin protein tags are attached to target proteins, leading to their degradation by proteasomes. Ubiquitination of NOS can reduce its abundance and activity.
3. **Inhibitors and Antagonists:**
- Several molecules can directly bind to and inhibit NOS activity. For example, L-NAME (Nω-nitro-L-arginine methyl ester) is a competitive inhibitor of NOS.
- NOS activity can also be indirectly regulated by antagonizing its cofactors, such as tetrahydrobiopterin (BH4).
4. **Cellular Environment:**
- Changes in cellular conditions, such as calcium levels, pH, and oxygen tension, can influence NOS activity and biosynthesis.
In summary, negative regulation of nitric-oxide synthase biosynthetic process is a complex and multifaceted process involving various molecular mechanisms that aim to control the production of NO within a physiological range. This regulation is essential to prevent excessive NO levels and maintain cellular homeostasis.'
"
Protein | Definition | Taxonomy |
---|---|---|
Glutathione S-transferase P | A glutathione S-transferase P that is encoded in the genome of human. [PRO:DNx, UniProtKB:P09211] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
ethacrynic acid | etacrynic acid : An aromatic ether that is phenoxyacetic acid in which the phenyl ring is substituted by chlorines at positions 2 and 3, and by a 2-methylidenebutanoyl group at position 4. It is a loop diuretic used to treat high blood pressure resulting from diseases such as congestive heart failure, liver failure, and kidney failure. It is also a glutathione S-transferase (EC 2.5.1.18) inhibitor. Ethacrynic Acid: A compound that inhibits symport of sodium, potassium, and chloride primarily in the ascending limb of Henle, but also in the proximal and distal tubules. This pharmacological action results in excretion of these ions, increased urinary output, and reduction in extracellular fluid. This compound has been classified as a loop or high ceiling diuretic. | aromatic ether; aromatic ketone; dichlorobenzene; monocarboxylic acid | EC 2.5.1.18 (glutathione transferase) inhibitor; ion transport inhibitor; loop diuretic |
d-alpha tocopherol | (R,R,R)-alpha-tocopherol : An alpha-tocopherol that has R,R,R configuration. The naturally occurring stereoisomer of alpha-tocopherol, it is found particularly in sunflower and olive oils. tocopherol : A collective name for a group of closely related lipids that contain a chroman-6-ol nucleus substituted at position 2 by a methyl group and by a saturated hydrocarbon chain consisting of three isoprenoid units. They are designated as alpha-, beta-, gamma-, and delta-tocopherol depending on the number and position of additional methyl substituents on the aromatic ring. Tocopherols occur in vegetable oils and vegetable oil products, almost exclusively with R,R,R configuration. Tocotrienols differ from tocopherols only in having three double bonds in the hydrocarbon chain. vitamin E : Any member of a group of fat-soluble chromanols that exhibit biological activity against vitamin E deficiency. The vitamers in this class consists of a chroman-6-ol core which is substituted at position 2 by a methyl group and (also at position 2) either a saturated or a triply-unsaturated hydrocarbon chain consisting of three isoprenoid units. The major function of vitamin E is to act as a natural antioxidant by scavenging free radicals and molecular oxygen. Vitamin E: A generic descriptor for all TOCOPHEROLS and TOCOTRIENOLS that exhibit ALPHA-TOCOPHEROL activity. By virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of ISOPRENOIDS. | alpha-tocopherol | algal metabolite; antiatherogenic agent; anticoagulant; antioxidant; antiviral agent; EC 2.7.11.13 (protein kinase C) inhibitor; immunomodulator; micronutrient; nutraceutical; plant metabolite |
hexylglutathione | S-hexylglutathione : An S-substituted glutathione that is glutathione in which the hydrogen of the thiol has been replaced by a hexyl group (PDB entry: 1PN9). | S-substituted glutathione | |
5-chloromethylfluorescein diacetate | acetate ester | fluorochrome | |
malagashanine | malagashanine: from Strychnos sp.; structure given in first source | ||
curcumin | curcumin : A beta-diketone that is methane in which two of the hydrogens are substituted by feruloyl groups. A natural dyestuff found in the root of Curcuma longa. Curcumin: A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes. | aromatic ether; beta-diketone; diarylheptanoid; enone; polyphenol | anti-inflammatory agent; antifungal agent; antineoplastic agent; biological pigment; contraceptive drug; dye; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; EC 1.8.1.9 (thioredoxin reductase) inhibitor; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; flavouring agent; food colouring; geroprotector; hepatoprotective agent; immunomodulator; iron chelator; ligand; lipoxygenase inhibitor; metabolite; neuroprotective agent; nutraceutical; radical scavenger |
ellagic acid | catechols; cyclic ketone; lactone; organic heterotetracyclic compound; polyphenol | antioxidant; EC 1.14.18.1 (tyrosinase) inhibitor; EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor; EC 2.4.1.1 (glycogen phosphorylase) inhibitor; EC 2.5.1.18 (glutathione transferase) inhibitor; EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor; EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor; EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; food additive; fungal metabolite; geroprotector; plant metabolite; skin lightening agent | |
2-crotonyloxymethyl-2-cyclohexenone | 2-crotonyloxymethyl-2-cyclohexenone: structure given in first source | ||
6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol | 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol: a specific glutathione S-transferase inhibitor; structure in first source | ||
flavellagic acid | flavellagic acid: RN given refers to parent cpd; structure |